Beverly B. Green MD, MPH, is a family physician at Group Health, a Seattle-based health care system and an associate investigator at it research arm, Group Health Research Institute. Her work focuses on leveraging health care informatics and systems approaches for improving population based health care. Her research has a strong public health emphasis, targeting conditions that impact large proportions of the population, such as cardiovascular disease, cancer, and obesity. With a goal of improving systems of care, she harnesses her experience as a family doctor to design and evaluate programs that make effective treatment easier for patients to follow through with—and easier for providers to deliver. She was the prior Associate Director of Group Health’s Department of Preventive Care and prior Associate Editor for the American Journal of Preventive Medicine.
Dr. Green is the principal investigator for the National Cancer Institute-supported Smart Options for Screening Study (SOS), an ongoing trial testing a centralized mailed FIT program and stepped intensity support to increase colorectal cancer (CRC) screening uptake. The study will be the first to report the effectiveness of ongoing mailed FIT kits on long-term screening adherence (up to 10 years). She is also the co-principal investigator along with Dr. Gloria Coronado of the Center for Health Research at Kaiser Permanente Northwest on the National Institutes of Health Common Fund’s STOP CRC pragmatic cluster trial that is testing whether an her-integrated FIT mailing program can be integrated into primary care quality improvement work to successfully increase CRC screening in disparity populations. STOP includes 26 safety net clinics and over 50,000 age-eligible patients not current for CRC screening. Drs. Green, Coronado, and Baldwin from the University of Washington, just embarked on a new Centers for Disease Control and Prevention-sponsored study, BeneFIT, to work with two health insurance plans (Care Oregon and Molina) to increase CRC screening in Medicaid and Medicare patients in Oregon and Washington.